SFRP2 and myocardial infarction: Among them, a lncRNA (AK137033) that we named Sfrp2 antisense as fibrosis enhancer (Safe) showed a continually increased expression in the mouse infarcted heart from day 5 to day 56 post MI, the stage of cardiac fibrogenesis and pathological remodeling (Figure 1C).